Q3 Revenue up 20% Year-Over-Year to $162.5 Million Q3 Net Income up 139% Year-Over-Year to $5.5 Million Q3 Gross Profit up 40% Year-Over-Year to ...

Achieved record gross bookings of $22.8 million and record revenue of $18.7 million Initiated cost-reduction actions expected to lower ...

Update on regulatory strategy for govorestat for the treatment of CMT-SORD following receipt of Type C meeting minutes – Meeting scheduled with the FDA in 4Q 2025 to discuss govorestat for the ...

Company Announced Completion of VERSATILE-002 Phase 2 trial of PDS0101 + Pembrolizumab in HPV16-Positive Recurrent/Metastatic Head and Neck Cancer Phase 2 Results Lead Company to Seek Expedited ...

Objectives To alleviate the shortage of qualified physicians in rural areas, since 2010, the Chinese government has launched a National Compulsory Service Programme (NCSP) to enrol medical students ...

IZEA will hold a conference call to discuss its third quarter 2025 results on Wednesday, November 12, 2025, at 5:00 p.m. EST.

Largo Inc. today released financial results for the three months and nine ended 30, 2025. The Company reported quarterly vanadium pentoxide equivalent sales of 2,417 tonnes at an adjusted cash ...